Literature DB >> 32567479

COVID-19 will change MS care forever - Commentary.

S C Krieger1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32567479     DOI： 10.1177/1352458520935719

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.

Authors:  Xavier Montalban; Jaume Sastre-Garriga; Alvaro Cobo-Calvo; Ana Zabalza; Jordi Río; Georgina Arrambide; Susana Otero-Romero; Paula Tagliani; Simón Cárdenas-Robledo; Mireia Castillo; Carmen Espejo; Marta Rodriguez; Pere Carbonell; Breogán Rodríguez; Luciana Midaglia; Ángela Vidal-Jordana; Carmen Tur; Ingrid Galan; Joaquín Castillo; Manuel Comabella; Carlos Nos; Cristina Auger; Mar Tintoré; Àlex Rovira
Journal:  J Neurol       Date:  2022-01-10       Impact factor: 6.682

2.  Description and preliminary experience with Virtual Visit Assessment (ViVA) during the COVID-19 pandemic, a structured virtual management protocol for patients with multiple sclerosis.

Authors:  Roberto Bergamaschi; Livio Tronconi; Daniele Bosone; Antonella Mastretti; Laura Jommi; Marco Andrè Bassano; Renato Turrini; Sara Benati; Marco Volpe; Jean Marie Franzini; Silvia Allodi; Giulia Mallucci
Journal:  Neurol Sci       Date:  2021-06-15       Impact factor: 3.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.